Delivery Order SPE2DR25D1017-SPE2DR26F9EAN
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,725.21 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $42,553.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management and diabetes treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $28,720.06 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $25,048.41 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $13,747.59 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (0.5 mL), a diabetes and weight management medication. This firm fixed-price contract, awarded on January 29, 2026, is a non-set-aside competitive award with a completion date of January 30, 2026, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $38,282.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on December 1, 2025, with a completion date of December 2, 2025. This firm fixed-price delivery order, issued under a competitive award with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract calls for the delivery of Zepbound, a GLP-1 receptor agonist...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injection on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-competitive, firm fixed-price delivery order represents a single shipment of the GLP-1 receptor agonist medication used for weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $2,410.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pens (0.5 ml units), a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed price, non-set-aside delivery order was awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a $15,621.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.56 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen (0.5 mL), a GLP-1 receptor agonist medication used for weight management. The award was issued on December 15, 2025, with an ultimate completion date of December 16, 2025, under firm fixed price terms with no set-aside designation. The contract represents a competitive award to the prime contractor, with performance of the delivery occurring at...